The Evolution of Controlled Release and Patient-centered Drug Delivery
Posted on January 27, 2014
By: Ralph Lipp, President and CEO
Lipp Life Sciences LLC
Introduction High interest in prolonged drug therapy for a variety of indications triggered significant research and development activities both in academia and industry already in the 1960s1,2. While in the beginning controlled release drug delivery systems (DDS) based on non-biodegradable polymer...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
Controlled Release, controlled release drug delivery systems (DDS), Patient-centered Drug Delivery
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
